SCHEMBL24916370

SCHEMBL24916370

CCc1cc(C(=O)NC2CN(C(=O)c3ccncc3)C2)c2nccc(C(C)CC)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 2/20 0.37
CHRM4 P08173 1/20 0.37
CSF1R P07333 1/20 0.37
KMT2A Q03164 1/20 0.36
GAA P10253 1/20 0.35
NPC1 O15118 1/20 0.34
F2R P25116 1/20 0.34
PKLR P30613 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA2B P29275 1/20 0.34
SMYD3 Q9H7B4 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP2D6 P10635 2/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
CHRNB2 P17787 2/20 0.32
CHRNB4 P30926 2/20 0.32
CHRNA3 P32297 2/20 0.32
CHRNA7 P36544 2/20 0.32
CHRNA4 P43681 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24915710 0.93 KDM5A (0.40) KDM5ACHRM4CSF1RKMT2AGAA
SCHEMBL24916371 0.82 MAP4K4 (0.39) KDM5AKMT2ASMYD3ALDH1A1
SCHEMBL24916193 0.81 CSF1R (0.38) CSF1RKMT2AGAANPC1SMN1; SMN2
SCHEMBL24915711 0.79 KDM5A (0.37) KDM5ACHRM4SMYD3TLR9TLR8
SCHEMBL24915712 0.79 KDM5A (0.40) KDM5ACHRM4CSF1RKMT2AGAA
SCHEMBL24915998 0.77 SMYD3 (0.47) KMT2ASMYD3ALDH1A1
SCHEMBL24915943 0.76 CNR2 (0.38) KDM5AF2RSMYD3CYP2D6CYP3A4
SCHEMBL24916002 0.75 SMYD3 (0.43) GAANPC1SMYD3SMN1; SMN2ALDH1A1
SCHEMBL24915529 0.75 HTR7 (0.42) KDM5ASMYD3ALDH1A1CHRNB2CHRNB4
SCHEMBL24916028 0.75 NAAA (0.42) KMT2AGAANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 KDM5A 188/4885CHRM4 4753/4885CSF1R 3562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.